These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1320049)

  • 1. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.
    Limonta P; Dondi D; Moretti RM; Maggi R; Motta M
    J Clin Endocrinol Metab; 1992 Jul; 75(1):207-12. PubMed ID: 1320049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D; Limonta P; Moretti RM; Marelli MM; Garattini E; Motta M
    Cancer Res; 1994 Aug; 54(15):4091-5. PubMed ID: 8033142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function.
    Marchetti B; Guarcello V; Morale MC; Bartoloni G; Farinella Z; Cordaro S; Scapagnini U
    Endocrinology; 1989 Aug; 125(2):1025-36. PubMed ID: 2546732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145.
    Moretti RM; Marelli MM; Dondi D; Poletti A; Martini L; Motta M; Limonta P
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3930-7. PubMed ID: 8923840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP.
    Limonta P; Dondi D; Moretti RM; Fermo D; Garattini E; Motta M
    J Clin Endocrinol Metab; 1993 Mar; 76(3):797-800. PubMed ID: 8445038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of LHRH agonists on the growth of human prostatic tumor cells: "in vitro" and "in vivo" studies.
    Montagnani Marelli M; Moretti RM; Dondi D; Limonta P; Motta M
    Arch Ital Urol Androl; 1997 Sep; 69(4):257-63. PubMed ID: 9396187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.
    Emons G; Schröder B; Ortmann O; Westphalen S; Schulz KD; Schally AV
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1458-64. PubMed ID: 8263128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.
    Chodak GW
    Urology; 1989 May; 33(5 Suppl):42-4. PubMed ID: 2523610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
    J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
    Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists.
    Eidne KA; Flanagan CA; Harris NS; Millar RP
    J Clin Endocrinol Metab; 1987 Mar; 64(3):425-32. PubMed ID: 3029154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.
    Emons G; Ortmann O; Becker M; Irmer G; Springer B; Laun R; Hölzel F; Schulz KD; Schally AV
    Cancer Res; 1993 Nov; 53(22):5439-46. PubMed ID: 8221683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
    Srkalovic G; Bokser L; Radulovic S; Korkut E; Schally AV
    Endocrinology; 1990 Dec; 127(6):3052-60. PubMed ID: 2174343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of LHRH and somatostatin analogs on human breast cancer.
    Brower ST; Schally AV; Redding TW; Hollander VP
    J Surg Res; 1992 Jan; 52(1):6-14. PubMed ID: 1347798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH.
    Limonta P; Moretti RM; Dondi D; Marelli MM; Motta M
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):347-50. PubMed ID: 8043499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells.
    Marelli MM; Moretti RM; Dondi D; Motta M; Limonta P
    Endocrinology; 1999 Jan; 140(1):329-34. PubMed ID: 9886842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
    Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
    Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway.
    Limonta P; Moretti RM; Marelli MM; Dondi D; Parenti M; Motta M
    Endocrinology; 1999 Nov; 140(11):5250-6. PubMed ID: 10537155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.